GMO GlobalSign Holdings K.K. (3788) · Target売上超過・利益率ROE未達
Full-Year Consolidated Financial Targets for the Fiscal Year Ending December 2022
First written in FY2021. . Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Setting and achieving performance targets under the medium-term management planA theme 791 companies write about · 75 as a headwind · 1062 as a tailwind
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 133 companies compared. The sentences above are computed from all 133.Comparing 200 of the theme's 1182 threads.Full recordFilings, disclosures and news, newest first
- FY2022売上超過・利益率ROE未達Annual report
「2022年12月期の計画に対する達成状況においては、売上高は15,960,064千円となり、計画比を773,064千円上回りました。売上高経常利益率は7.6％となり計画値の10.0％を2.4ポイント下回りました。また、ROE（自己資本利益率）は11.2％となり、計画値の12.2%より1.0ポイント下回りました。」
2022年12月期は売上高が計画を5.1％上回った一方、売上高経常利益率とROEは計画を下回った。 - FY2021First statedAnnual report
「As a result, for the full fiscal year ending December 2022, we forecast revenue of ¥15,187 million, up 8.1% year on year; operating profit of ¥1,524 million, up 30.1%; ordinary profit of ¥1,521 million, up 26.8%; and net income attributable to owners of the parent of ¥900 million, up 86.1%.」
2022年12月期について、売上高15,187百万円、営業利益1,524百万円、経常利益1,521百万円、親会社株主に帰属する当期純利益900百万円の通期目標を設定している。